Chuangyebang learned from the media that recently, Jiangsu Zhenyi Medical Technology Co., Ltd. (hereinafter referred to as Zhenyi Medical) completed hundreds of millions of yuan in Pre-B round financing, led by Daohe Long-term Investment, and participated by many parties. Shares, Jifeng Capital, etc. continued to support. On the one hand, this financing will continue to be used for the innovative development and clinical research of Zhenyi Medical’s products in the cardiovascular field; on the other hand, it will actively promote the commercialization of Zhenyi products, accelerate the launch of products, and meet the urgent clinical needs of millions of patients with cardiovascular diseases. need.
Zhenyi Medical is a highly innovative high-end medical device enterprise. Since its establishment, it has been on the fast track of development and innovation. The company focuses on disease areas with extremely high fatality and disability rates and the domestic market is still blank, with comprehensive business coverage. It has become the first domestic platform-based high-end medical device company with a full layout of the four major golden tracks and substantial progress in core products in the four major disease areas of heart valve, heart failure, peripheral and coronary artery.
At present, Zhenyi Medical has applied for more than 160 patents, 80% of which are invention patents, more than 40 PCT international patents, and more than 15 research projects, including mitral valve repair, tricuspid valve repair, mitral valve replacement, shock wave balloon Four blockbuster products are being registered for clinical rapid enrollment, and the high-quality clinical trial results have been widely recognized by many patients, clinicians and industry peers. More innovative products such as pulmonary thrombectomy, aortic valve stem valve and shunt followed closely and entered the clinical stage this year.
The chairman of Zhenyi Medical said: “The vitality of a medical device product lies in its safety and effectiveness. The products of Zhenyi Medical have withstood the initial test in the clinic. Under the condition of ensuring the safety and effectiveness of the product, we hope to further Breaking through the technical problem of ‘stuck neck’ in foreign countries and realizing lower cost and better products will bring benefits to the vast number of patients with cardiovascular disease, and will also bring very broad development prospects to Zhenyi Medical.”
media coverage
China Investment Network Yiou Entrepreneurship State
Related events
- Zhenyi Medical received hundreds of millions of yuan in Pre-B round financing2022-09-09
- Xuanyu Medical completes 100 million yuan Series A financing2022-06-21
- Huichuang Medical received nearly 100 million yuan of Pre-B round financing2022-06-02
- Spectra Medical Completes 100 Million Yuan Series A Financing2022-05-07
- Weike Medical completed hundreds of millions of RMB in Series B financing, led by Sequoia China2021-12-16
This article is reprinted from: https://readhub.cn/topic/8jabeKDCzeG
This site is for inclusion only, and the copyright belongs to the original author.